Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthcare TriangleHCTI +5.04%19 EV-to-EBITDA is -2.82 as of Aug. 10, 2026. GuruFocus rates HCTI with a GF Score™ of 19/100. The stock has 7 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Healthcare Triangle ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Healthcare Triangle's enterprise value is $34.44 Mil.
Healthcare Triangle's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-12.23 Mil. Therefore, Healthcare Triangle's EV-to-EBITDA for today is -2.82.
The historical rank and industry rank for Healthcare Triangle's EV-to-EBITDA or its related term are showing as below:
HCTI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.91 Med: -2.78 Max: -0.46
Current: -2.82
During the past 7 years, the highest EV-to-EBITDA of Healthcare Triangle was -0.46. The lowest was -10.91. And the median was -2.78.
HCTI's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 10.965
vs HCTI: -2.82
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Healthcare Triangle's PE Ratio (TTM) for today is calculated as:
Healthcare Triangle's share price for today is $1.24.
Healthcare Triangle's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-98.806.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Healthcare Triangle's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Healthcare Triangle's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare Triangle EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healthcare Triangle's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Healthcare Triangle's EV-to-EBITDA falls into.
Healthcare Triangle's current Enterprise Value is $34.44 Mil.
Healthcare Triangle's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare Triangle (HCTI) has a EV-to-EBITDA of -2.82 as of Aug. 10, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healthcare Triangle. According to the industry distribution chart, Healthcare Triangle ranks #999999 out of 512 companies in the Healthcare Providers & Services industry.
Is Healthcare Triangle's EV-to-EBITDA too high?
Healthcare Triangle's current EV-to-EBITDA is -2.82. Based on the distribution chart, Healthcare Triangle ranks #999999 out of 512 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Healthcare Triangle has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Healthcare Triangle's EV-to-EBITDA compare to VSEE and MNDR?
According to the Healthcare Providers & Services industry distribution chart, Healthcare Triangle ranks #999999 out of 512 companies for EV-to-EBITDA. This places Healthcare Triangle in the lower half of its industry. The industry median EV-to-EBITDA is 10.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.97, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healthcare Triangle. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare Triangle's current EV-to-EBITDA is -2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare Triangle stock overvalued right now?
Healthcare Triangle (HCTI) has a current EV-to-EBITDA of -2.82. The current EV-to-EBITDA is -2.82. Healthcare Triangle's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Healthcare Triangle (HCTI), the current EV-to-EBITDA is -2.82 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.
19GF Score
Get the complete analysis for HCTI
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCTI has been successfully added to your 
